SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Berger who wrote (423)3/3/1997 1:22:00 PM
From: jeeza   of 1172
 
the Good, Bad and the Ugly

the good news...and there is plenty

1.FDA clearance for "improved performance claims"
2. milestone payment by merck-astra
3. company pushing to start consumer trials so to get FDA approval to market test as an OTC test
do I see a multi-million dollar product !!!

Q. why is astra-merck just marketing HpChek in USA...why not europe ?
Is CMTR looking for partners in Japan and other countries ?
today's press release indicates there is a huge market for this product

CEO is pushing Cholestrak + Colocare in every press release
would like to see some analyst coverage once we start trading at a decent price of $4-5

as someone mentioned in past posts Colocare may bring in significant revenues even though CMTR just distributes it...Cholestrak will also gain consumer attention when marketed with Colocare

now the bad news
"sweet" Alene is leaving....heh heh...besides Dan who invested in CMTR just for Alene ;) ...(Dan just joking)

the UGLY news
10% of us will suffer from ulcers..and will soon be using HpChek and Prilosec...esp if we keep watching CMTR on a tick by tick basis ;)

have a nice day Chem-trekkers

ps: HIV test coming soon , theophylline test maybe submitted in coming future, some global contract for Cholestrak,HpChek,Colocare

party has just begun :-))
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext